Quantitative CT analysis to predict esophageal fistula in patients with advanced esophageal cancer treated by chemotherapy or chemoradiotherapy

被引:6
|
作者
Shi, Yan-Jie [1 ]
Liu, Chang [2 ]
Wei, Yi-Yuan [1 ]
Li, Xiao-Ting [1 ]
Shen, Lin [2 ]
Lu, Zhi-Hao [2 ]
Sun, Ying-Shi [1 ]
机构
[1] Peking Univ Canc Hosp & Inst, Dept Radiol, Minist Educ, Key Lab Carcinogenesis & Translat Res, 52 Fu Cheng Rd, Beijing 100142, Peoples R China
[2] Peking Univ Canc Hosp & Inst, Dept Gastrointestinal Oncol, Minist Educ, Key Lab Carcinogenesis & Translat Res, 52 Fu Cheng Rd, Beijing 100142, Peoples R China
基金
中国国家自然科学基金; 北京市自然科学基金;
关键词
Esophageal squamous cell cancer; X-ray computed tomography; Esophageal fistula; Risk factor; Chemoradiotherapy; SQUAMOUS-CELL CARCINOMA; RISK-FACTORS; ANGIOGENESIS; SURGERY;
D O I
10.1186/s40644-022-00490-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Esophageal fistula is one of the most serious complications of chemotherapy or chemoradiotherapy (CRT) for advanced esophageal cancer. This study aimed to evaluate the performance of quantitative computed tomography (CT) analysis and to establish a practical imaging model for predicting esophageal fistula in esophageal cancer patients treated with chemotherapy or chemoradiotherapy. Methods This study retrospectively enrolled 204 esophageal cancer patients (54 patients with fistula, 150 patients without fistula) and all patients were allocated to the primary and validation cohorts according to the time of inclusion in a 1:1 ratio. Ulcer depth, tumor thickness and length, and minimum and maximum enhanced CT values of esophageal cancer were measured in pretreatment CT imaging. Logistic regression analysis was used to evaluate the associations of CT quantitative measurements with esophageal fistula. Receiver operating characteristic curve (ROC) analysis was also used. Results Logistic regression analysis showed that independent predictors of esophageal fistula included tumor thickness [odds ratio (OR) = 1.167; p = 0.037], the ratio of ulcer depth to adjacent tumor thickness (OR = 164.947; p < 0.001), and the ratio of minimum to maximum enhanced CT value (OR = 0.006; p = 0.039) in the primary cohort at baseline CT imaging. These predictors were used to establish a predictive model for predicting esophageal fistula, with areas under the receiver operating characteristic curves (AUCs) of 0.946 and 0.841 in the primary and validation cohorts, respectively. The quantitative analysis combined with T stage for predicting esophageal fistula had AUCs of 0.953 and 0.917 in primary and validation cohorts, respectively. Conclusion Quantitative pretreatment CT analysis has excellent performance for predicting fistula formation in esophageal cancer patients who treated by chemotherapy or chemoradiotherapy.
引用
收藏
页数:12
相关论文
共 50 条
  • [1] Quantitative CT analysis to predict esophageal fistula in patients with advanced esophageal cancer treated by chemotherapy or chemoradiotherapy
    Yan-Jie Shi
    Chang Liu
    Yi-Yuan Wei
    Xiao-Ting Li
    Lin Shen
    Zhi-Hao Lu
    Ying-Shi Sun
    Cancer Imaging, 22
  • [2] Analysis of fistula formation of T4 esophageal cancer patients treated by chemoradiotherapy
    Taniyama, Tomoko Katsui
    Tsuda, Takashi
    Miyakawa, Kunihisa
    Arai, Hiroyuki
    Doi, Ayako
    Hirakawa, Mami
    Horie, Yoshiki
    Mizukami, Takuro
    Izawa, Naoki
    Ogura, Takashi
    Sunakawa, Yu
    Nakajima, Takako Eguchi
    ESOPHAGUS, 2020, 17 (01) : 67 - 73
  • [3] Analysis of fistula formation of T4 esophageal cancer patients treated by chemoradiotherapy
    Tomoko Katsui Taniyama
    Takashi Tsuda
    Kunihisa Miyakawa
    Hiroyuki Arai
    Ayako Doi
    Mami Hirakawa
    Yoshiki Horie
    Takuro Mizukami
    Naoki Izawa
    Takashi Ogura
    Yu Sunakawa
    Takako Eguchi Nakajima
    Esophagus, 2020, 17 : 67 - 73
  • [4] Outcome of Locally Advanced Esophageal Cancer Patients Treated With Perioperative Chemotherapy and Chemoradiotherapy Followed by Surgery
    Ahmed, Naseer
    Owen, Justin
    Abdalmassih, Michael
    Khan, Junaid
    Nugent, Zoann
    Qing, Gefei
    Martineau, Patrick
    Rathod, Shrinivas
    Dubey, Arbind
    Bashir, Bashir
    Chowdhury, Amitava
    Buduhan, Gordon
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2021, 44 (01): : 10 - 17
  • [5] OUTCOME OF LOCALLY ADVANCED ESOPHAGEAL CANCER PATIENTS TREATED WITH PERIOPERATIVE CHEMOTHERAPY AND CHEMORADIOTHERAPY FOLLOWED BY SURGERY
    Owen, Justin
    Abdalmassih, Michael
    Khan, Junaid
    Nugent, Zoann
    Buduhan, Gordon
    Ahmed, Naseer
    RADIOTHERAPY AND ONCOLOGY, 2020, 150 : S48 - S48
  • [6] Outcome Of Locally Advanced Esophageal Cancer Patients Treated With Perioperative Chemotherapy And Chemoradiotherapy Followed By Surgery
    Owen, J.
    Abdalmassih, M.
    Khan, J.
    Nugent, Z.
    Buduhan, G.
    Ahmed, N.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03): : E654 - E654
  • [7] Neoadjuvant chemoradiotherapy or chemotherapy for locally advanced esophageal cancer?
    Babic, B.
    Fuchs, H. F.
    Bruns, C. J.
    CHIRURG, 2020, 91 (05): : 379 - 383
  • [8] Neoadjuvant Chemotherapy or Chemoradiotherapy for Locally Advanced Esophageal Cancer
    Smithers, B. Mark
    Thomson, Iain
    THORACIC SURGERY CLINICS, 2013, 23 (04) : 509 - +
  • [9] Outcomes for patients with locally advanced esophageal cancer treated with palliative chemoradiotherapy
    Jayasekera, C. S.
    Byram, D.
    Gauden, S.
    Mitchell, B.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A184 - A184
  • [10] Risk factors for esophageal fistula in patients with locally advanced esophageal carcinoma receiving chemoradiotherapy
    Zhang, Yang
    Li, Zongjuan
    Zhang, Wei
    Chen, Wei
    Song, Yipeng
    ONCOTARGETS AND THERAPY, 2018, 11 : 2311 - 2317